Furthermore, high levels of p-Erk1/2 correlate with decreased survival in BC patients, suggesting that Erk1/2-mediated Bik degradation plays a role in chemotherapy resistance, such as to 5-fluorouracil, and impacts disease progression [78]. This evidence concerns the gene BIK and breast cancer.